Establishing biomarkers for soft tissue sarcomas
The result's identifiers
Result code in IS VaVaI
<a href="https://www.isvavai.cz/riv?ss=detail&h=RIV%2F61989100%3A27740%2F24%3A10255832" target="_blank" >RIV/61989100:27740/24:10255832 - isvavai.cz</a>
Result on the web
<a href="https://www.tandfonline.com/doi/full/10.1080/14737140.2024.2346187" target="_blank" >https://www.tandfonline.com/doi/full/10.1080/14737140.2024.2346187</a>
DOI - Digital Object Identifier
<a href="http://dx.doi.org/10.1080/14737140.2024.2346187" target="_blank" >10.1080/14737140.2024.2346187</a>
Alternative languages
Result language
angličtina
Original language name
Establishing biomarkers for soft tissue sarcomas
Original language description
IntroductionSoft tissue sarcomas (STS) are a rare and diverse group of tumors. Curative options are limited to localized disease, with surgery being the mainstay. Advanced stages are associated with a poor prognosis. Currently, the prognosis of the patient is based on histological classification and clinical characteristics, with only a few biomarkers having entered clinical practice.Areas coveredThis article covers extensive recent research that has established novel potential biomarkers based on genomics, proteomics, and clinical characteristics. Validating and incorporating these biomarkers into clinical practice can improve prognosis, prediction of recurrence, and treatment response. Relevant literature was collected from PubMed, Scopus, and clinicaltrials.gov databases (November 2023).Expert opinionCurrently, defining prognostic markers in soft tissue sarcomas remains challenging. More studies are required, especially to personalize treatment through advanced genetic profiling and analysis using individual tumor and patient characteristics.
Czech name
—
Czech description
—
Classification
Type
J<sub>imp</sub> - Article in a specialist periodical, which is included in the Web of Science database
CEP classification
—
OECD FORD branch
30204 - Oncology
Result continuities
Project
—
Continuities
—
Others
Publication year
2024
Confidentiality
S - Úplné a pravdivé údaje o projektu nepodléhají ochraně podle zvláštních právních předpisů
Data specific for result type
Name of the periodical
Expert Review of Anticancer Therapy
ISSN
1473-7140
e-ISSN
1744-8328
Volume of the periodical
24
Issue of the periodical within the volume
6
Country of publishing house
GB - UNITED KINGDOM
Number of pages
15
Pages from-to
407-421
UT code for WoS article
001209884100001
EID of the result in the Scopus database
2-s2.0-85192051439